Exscientia plc is a pharmatech company that uses artificial intelligence (AI) to discover, design, and develop drugs. They specialize in small molecule drug candidates and provide end-to-end AI solutions for target identification, drug candidate design, translational models, and patient selection. Founded in 2012 and headquartered in the United Kingdom, their platform allows for AI-guided drug therapy assessment and designing candidate drug molecules.